Table 2 Recurrences, deaths, and median HU177 levels by stage
From: Increased shedding of HU177 correlates with worse prognosis in primary melanoma
Stage | Recurrences | Deaths | Median HU177 (ng/ml) |
|---|---|---|---|
I (n = 136) | 9 (7%) | 9 (7%) | 3.66 |
II (n = 41) | 11 (27%) | 10 (24%) | 3.91 |
III (n = 32) | 18 (56%) | 15 (47%) | 3.89 |